Puma Bio (PBYI) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

Puma Bio Revenue Highlights

Latest Revenue (Y)

$235.64M

Latest Revenue (Q)

$56.14M

Main Segment (Y)

Royalty

Main Geography (Y)

Royalty

Puma Bio Revenue by Period

Puma Bio Revenue by Year

Date	Revenue	Change
2023-12-31	$235.64M	3.35%
2022-12-31	$228.00M	-9.95%
2021-12-31	$253.20M	12.48%
2020-12-31	$225.10M	-17.33%
2019-12-31	$272.30M	8.49%
2018-12-31	$251.00M	806.14%
2017-12-31	$27.70M	100.00%
2016-12-31	-	100.00%
2015-12-31	-	100.00%
2014-12-31	-	100.00%
2013-12-31	-	100.00%
2012-12-31	-	-100.00%
2011-12-31	$-281.10K	100.00%
2010-12-31	-	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	-

Puma Bio generated $235.64M in revenue during NA 2023, up 3.35% compared to the previous quarter, and up 93.88% compared to the same period a year ago.

Puma Bio Revenue by Quarter

Date	Revenue	Change
2024-09-30	$56.14M	19.23%
2024-06-30	$47.08M	7.58%
2024-03-31	$43.77M	-39.36%
2023-12-31	$72.18M	28.62%
2023-09-30	$56.12M	2.84%
2023-06-30	$54.57M	3.40%
2023-03-31	$52.77M	-19.67%
2022-12-31	$65.70M	15.06%
2022-09-30	$57.10M	-4.06%
2022-06-30	$59.52M	30.13%
2022-03-31	$45.74M	-17.44%
2021-12-31	$55.40M	19.80%
2021-09-30	$46.24M	-13.37%
2021-06-30	$53.38M	-45.62%
2021-03-31	$98.17M	86.63%
2020-12-31	$52.60M	3.64%
2020-09-30	$50.75M	-28.09%
2020-06-30	$70.58M	37.81%
2020-03-31	$51.22M	-18.57%
2019-12-31	$62.90M	11.52%
2019-09-30	$56.40M	4.60%
2019-06-30	$53.92M	-45.59%
2019-03-31	$99.10M	39.38%
2018-12-31	$71.10M	13.58%
2018-09-30	$62.60M	23.31%
2018-06-30	$50.77M	-23.68%
2018-03-31	$66.52M	207.94%
2017-12-31	$21.60M	255.44%
2017-09-30	$6.08M	100.00%
2017-06-30	-	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

Puma Bio generated $56.14M in revenue during Q3 2024, up 19.23% compared to the previous quarter, and up 102.87% compared to the same period a year ago.

Puma Bio Revenue Breakdown

Puma Bio Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 20	Dec 19	Dec 18
Royalty	$5.68M	$391.00K	-
License	$2.50M	$60.25M	$50.50M
Product	-	$211.62M	$200.49M

Puma Bio's latest annual revenue breakdown by segment (product or service), as of Dec 20: Royalty (69.45%), and License (30.55%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18
Royalty	$24.41M	$2.69M	$4.28M	$2.35M	$2.54M	$1.42M	$1.11M	$608.00K	$216.00K	$120.00K	$55.00K	-	-	-	-
Product	$56.14M	$44.40M	$48.86M	$50.02M	$48.77M	$48.61M	$58.71M	$53.48M	$53.86M	$45.57M	$61.08M	$52.63M	$50.77M	-	-
License	-	-	$250.00K	$2.50M	$2.70M	$20.70M	$2.00M	$4.00M	$2.75M	-	$53.50M	$10.00M	$10.00M	$30.50M	-

Puma Bio's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (69.70%), and Royalty (30.30%).

Puma Bio Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 20	Dec 19	Dec 18
Royalty	$5.68M	$391.00K	-
License	$2.50M	$60.25M	$50.50M
Product	-	$211.62M	$200.49M

Puma Bio's latest annual revenue breakdown by geography, as of Dec 20: Royalty (69.45%), and License (30.55%).

Quarterly Revenue by Country

Country	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18
Royalty	$4.28M	$2.35M	$2.54M	$1.42M	$1.11M	$608.00K	$216.00K	$120.00K	$55.00K	-	-	-	-
Product	$48.86M	$50.02M	$48.77M	$48.61M	$58.71M	$53.48M	$53.86M	$45.57M	$61.08M	$52.63M	$50.77M	-	-
License	$250.00K	$2.50M	$2.70M	$20.70M	$2.00M	$4.00M	$2.75M	-	$53.50M	$10.00M	$10.00M	$30.50M	-

Puma Bio's latest quarterly revenue breakdown by geography, as of Jun 21: Product (91.52%), Royalty (8.01%), and License (0.47%).

Puma Bio Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SRPT	Sarepta Therapeutics	$1.24B	$362.93M
PTCT	PTC Therapeutics	$937.82M	$135.42M
RARE	Ultragenyx Pharmaceutical	$434.25M	$147.03M
CHRS	Coherus BioSciences	$257.24M	$70.77M
PBYI	Puma Bio	$235.64M	$56.14M
HRTX	Heron Therapeutics	$127.04M	$36.02M
TSVT	2seventy bio	$100.39M	$13.53M
ARVN	Arvinas	$78.50M	$102.40M
MGNX	MacroGenics	$58.75M	$110.71M
RVMD	Revolution Medicines	$11.58M	-
CRNX	Crinetics Pharmaceuticals	$4.01M	-
IOVA	Iovance Biotherapeutics	$1.19M	$58.55M
VKTX	Viking Therapeutics	-	-
KURA	Kura Oncology	-	-
MDGL	Madrigal Pharmaceuticals	-	$62.17M
LRMR	Larimar Therapeutics	-	-
HEPA	Hepion Pharmaceuticals	-	-

PBYI Revenue FAQ

What is Puma Bio’s yearly revenue?

Puma Bio's yearly revenue for 2023 was $235.64M, representing an increase of 3.35% compared to 2022. The company's yearly revenue for 2022 was $228M, representing a decrease of -9.95% compared to 2021. PBYI's yearly revenue for 2021 was $253.2M, representing an increase of 12.48% compared to 2020.

What is Puma Bio’s quarterly revenue?

Puma Bio's quarterly revenue for Q3 2024 was $56.14M, a 19.23% increase from the previous quarter (Q2 2024), and a 0.04% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $47.08M, a 7.58% increase from the previous quarter (Q1 2024), and a -13.72% decrease year-over-year (Q2 2023). PBYI's quarterly revenue for Q1 2024 was $43.77M, a -39.36% decrease from the previous quarter (Q4 2023), and a -17.07% decrease year-over-year (Q1 2023).

What is Puma Bio’s revenue growth rate?

Puma Bio's revenue growth rate for the last 3 years (2021-2023) was -6.94%, and for the last 5 years (2019-2023) was -13.46%.

What are Puma Bio’s revenue streams?

Puma Bio's revenue streams in c 20 are Royalty, and License. Royalty generated $5.68M in revenue, accounting 69.45% of the company's total revenue, up 1353.20% year-over-year. License generated $2.5M in revenue, accounting 30.55% of the company's total revenue, down -95.85% year-over-year.

What is Puma Bio’s main source of revenue?

For the fiscal year ending Dec 20, the largest source of revenue of Puma Bio was Royalty. This segment made a revenue of $5.68M, representing 69.45% of the company's total revenue.